Decoys for misguided antibodies restore antiviral immune defense, study shows

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body’s own antibodies, which inhibit important defense proteins known as type I interferons. UZH researchers have now generated “decoy molecules” that intercept these autoantibodies and restore the immune defense—the foundation for a possible new therapy.

Improved muscle mapping could aid neurological treatment

Researchers from Carnegie Mellon University have developed a cutting-edge method to identify muscle activity in densely packed regions like the forearm. Using high-density surface electromyography (HD-sEMG) sensors alongside other techniques such as peripheral nerve stimulation, spatial filtering, and ultrasound imaging, this approach offers more accurate identification of muscle activity.

Study suggests former inmates struggle to access medical care—even when it’s nearly free

As they studied two years of prison-inmate data, Laura Dague and a team of fellow health researchers noticed that one particular scenario kept cropping up. That scenario involved the days when an inmate is released and returns to their community. A significant number were released with chronic health issues and promptly signed up for government-subsidized health care—only to stop taking their medications.